Sudarshan Pharma promoter releases pledge on 2 lakh shares
- Promoter Mr. Hemal Mehta released pledge on 2,00,000 equity shares
- Pledge release occurred on August 6, 2026
- Original encumbrance was for personal loans taken by the promoter
- Disclosure filed with BSE on September 9, 2026
- Mehta holds 26.60% stake (6,40,21,020 shares) in the company
*this image is generated using AI for illustrative purposes only.
Sudarshan Pharma Industries disclosed the release of a pledge on 2,00,000 equity shares held by its promoter, Mr. Hemal Mehta. The release was executed on August 6, 2026.
The company submitted the revised disclosure to BSE Limited on September 9, 2026, in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing serves as an intimation regarding the removal of encumbrance from the promoter's holding.
Pledge Release Details
The pledged shares were originally encumbered to secure a loan taken by Mr. Mehta for personal reasons. The release of the pledge reduces the number of shares held under lien by the promoter.
| Metric | Details |
|---|---|
| Promoter | Mr. Hemal Vasantrai Mehta |
| Event Type | Release of Pledge |
| Number of Shares | 2,00,000 |
| Date of Event | August 6, 2026 |
| Reason for Encumbrance | Personal loan |
Mr. Mehta currently holds 6,40,21,020 equity shares in Sudarshan Pharma Industries, representing 26.60% of the total share capital. The disclosure does not specify the remaining number of pledged shares following this release, nor does it detail the specific entity in whose favor the shares were previously encumbered.
The company's compliance officer, Nirav Shah, signed the intimation letter addressed to the Listing Department of BSE Limited. The filing references an earlier email from the exchange dated September 4, 2026, requesting the revised disclosure.
Historical Stock Returns for Sudarshan Pharma Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.24% | -0.05% | +20.74% | +51.05% | +21.42% | 0.0% |
How does the release of this pledge impact Mr. Hemal Mehta's overall leverage ratio and financial flexibility for future corporate initiatives?
What are the implications of the undisclosed remaining pledged shares on investor confidence and potential margin call risks?
Could this reduction in encumbrance signal an upcoming strategic move, such as a rights issue or further capital raising by the promoter?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
